Bysani Chandrasekar, Srinivas Mummidi, Vincent G. DeMarco, & Yusuke Higashi. (2023). Empagliflozin Reverses Oxidized LDL-Induced RECK Suppression, Cardiotrophin-1 Expression, MMP Activation, and Human Aortic Smooth Muscle Cell Proliferation and Migration. Hindawi Limited.
Chicago Style (17th ed.) CitationBysani Chandrasekar, Srinivas Mummidi, Vincent G. DeMarco, and Yusuke Higashi. Empagliflozin Reverses Oxidized LDL-Induced RECK Suppression, Cardiotrophin-1 Expression, MMP Activation, and Human Aortic Smooth Muscle Cell Proliferation and Migration. Hindawi Limited, 2023.
MLA (9th ed.) CitationBysani Chandrasekar, et al. Empagliflozin Reverses Oxidized LDL-Induced RECK Suppression, Cardiotrophin-1 Expression, MMP Activation, and Human Aortic Smooth Muscle Cell Proliferation and Migration. Hindawi Limited, 2023.